LY450139 dihydrate (semagacestat)

semagacestat · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY450139 dihydrate (semagacestat), covering 2007-05-28 to 2007-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]